Analysts Update Their Price Forecasts For Advaxis Inc. (ADXS)


    BlackRock Fund Advisors has recently announced that it has increased stake in Advaxis Inc. (NASDAQ:ADXS) by 2.70%. After grabbing 0.87 million shares, the institutional investor is now in possession of 22909.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.41% having worth around $0.5 million. Moreover, The Vanguard Group, Inc. increased its share by 5900.0 to have a control over 0.81 million shares. And Bridgeway Capital Management, Inc.. raised its holdings to 0.25 million shares by acquiring 0.25 million shares or 0.41% of the stake.

    Advaxis Inc. (ADXS) concluded trading on 08/27/20 at a closing price of $0.48, with 1.95 million shares of worth about $0.94 million changed hands on the day. Weekly performance of the stock remained positive as price took a surge of 0.02% during that period and on Thursday the price saw a gain of about 5.66%. Currently the company’s common shares owned by public are about 60.57M shares, out of which, 48.23M shares are available for trading.

    A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analyst is covering the ADXS stock and their offered price forecasts bring an average price target of $5.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $5.00 and could fall to a lowest price of $5.00. Analysts also issued an outlook of 2.00 for the Advaxis Inc. stock for next 12 months. However, touching the estimated high of $5.00 would mean a gain of 90.4% for the stock.

    According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 3 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 3 selling transactions, insiders dumped 3,000 shares.

    Vanguard Extended Market Index Fu, Fidelity Extended Market Index Fu, and Bridgeway Ultra Small Company Mar are the top 3 mutual funds which are holding stakes in Advaxis Inc. Vanguard Extended Market Index Fu is currently holding 0.81 million shares of worth totaling $0.47 million. The company recently came buying 0.0 shares which brought its stake up to 1.32% of the company’s outstanding shares. Bridgeway Ultra Small Company Mar, after buying 0.16 million shares, have now control over 0.25% of the stake in the company. It holds 0.16 million shares of worth $90248.0.

    Advaxis Inc. (NASDAQ: ADXS) started trading at $0.4545, below $0.0 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $0.48, or with a gain of 5.66%. Stock saw a price change of 0.02% in past 5 days and over the past one month there was a price change of -20.27%. Year-to-date (YTD), ADXS shares are showing a performance of -44.25% which increased to 38.81% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.21 but also hit the highest price of $1.48 during that period. While comparing its average daily trading volume of 1.15 million shares, we see that about 1.95 million changed hands on the day. The stock is currently trading -9.44% below its 20-day simple moving average (SMA20), while that difference is down -14.66% for SMA50 and it goes to -30.86% lower than SMA200.

    BlackRock Fund Advisors acquired 0.87 million shares of Advaxis Inc. having value of about $0.5 million. Data submitted at the U.S SEC by BlackRock Fund Advisors revealed that the firm now holds 22909.0 shares in the company valued at close to $10996.32, or have control over 2.70% stake in the company. Advaxis Inc. (NASDAQ: ADXS) currently have 60.57M outstanding shares and institutions hold larger chunk of about 19.70% of that. Holding of mutual funds in the company is about 2.34% while other institutional holders and individual stake holders have control over 9.36% and 0.11% of the stake respectively.

    The stock has a current market capitalization of $30.53M and its 3Y-monthly beta is at 3.59. It has posted earnings per share of -$1.51 in the same period. It has Quick Ratio of 7.50 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ADXS, volatility over the week remained 7.86% while standing at 6.81% over the month.

    Analysts are in expectations that Advaxis Inc. (ADXS) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter ESPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.96 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 94.40%.

    Analysts at 1 brokerage firms have issued recommendations for the Advaxis Inc. (ADXS)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.

    Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barclays on August 03, 2016 offering an Overweight rating for the stock and assigned a target price range of between $15 and $20 to it. Coverage by Barclays stated Advaxis Inc. (ADXS) stock as an Overweight in their note to investors on September 22, 2015, suggesting a price target of $40 for the stock. On September 11, 2015, Guggenheim Initiated their recommendations, while on June 16, 2015, H.C. Wainwright Reiterated their ratings for the stock with a price target of $30. Stock get a Buy rating from Jefferies on May 15, 2015.


    Please enter your comment!
    Please enter your name here